Activism: latest news

Activism features

Activism in your own words

Activism news from aidsmap

  • France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic

    France is launching a new study which will enrol 3000 new pre-exposure prophylaxis (PrEP) users over the next three years, Jean-Michel Molina told the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris this week. Whereas previous studies, ...

    28 July 2017 | Roger Pebody
  • Hope overshadowed – the US PrEP Summit

    The US National HIV PrEP Summit, which took place in early December in San Francisco, was one of the most extraordinary HIV meetings I have ever been to. This first-ever gathering of 600 people involved in ...

    31 January 2017 | Gus Cairns
  • Policy makers’ inaction is leading people to take PrEP ‘in the wild’

    An increasing number of gay men and others at risk of HIV are seeking to protect their health with PrEP (pre-exposure prophylaxis), but the lack of PrEP provision and lack of regulatory approval in many countries is leading ...

    19 October 2016 | Roger Pebody
  • Gains in curbing HIV epidemic could be lost without continued commitment, AIDS 2016 speakers say

    Participants at the 21st International AIDS Conference (AIDS 2016), taking place this week in Durban, South Africa, reviewed the remarkable gains that have been made in access to HIV treatment and new prevention tools since the conference was last held ...

    19 July 2016 | Liz Highleyman
  • People who inject drugs have other priorities ahead of PrEP

    People who inject drugs have fundamental concerns about HIV pre-exposure prophylaxis (PrEP) and the manner in which it is being promoted, according to a consultation conducted by the International Network of People who Use Drugs (INPUD). With limited availability ...

    17 June 2016 | Roger Pebody
  • England’s PrEP policy in disarray after NHS U-turn

    Activists, individuals at risk of HIV, and clinicians have reacted with anger to an official U-turn on provision of HIV pre-exposure prophylaxis (PrEP). NHS England officials have refused to allow a draft policy on PrEP to go forward for ...

    22 March 2016 | Roger Pebody
  • London sexual health clinics step up their support for people buying PrEP online

    Several large sexual health clinics in London and Brighton have responded to the growing numbers of people importing PrEP medications from overseas by offering free safety monitoring to PrEP users. This is in a context of increasing frustration with ...

    29 January 2016 | Roger Pebody
  • France approves PrEP

    In a historic move, France has become the first country outside the USA, and the first country with a centrally-organised, reimbursable health system, to approve no-expense pre-exposure prophylaxis (PrEP) for people who need it.The French Minister of Health, ...

    24 November 2015 | Gus Cairns
  • Harm reduction conference calls for political leadership to reform drugs policy

    The biggest challenges to harm reduction are drugs policy and drugs laws, the Malaysian harm reduction leader Dr Adeeba Kamarulzaman told the 24th International Harm Reduction Conference in Kuala Lumpur last week.Numerous speakers said that punitive and prohibitionist drugs policies have restricted ...

    27 October 2015 | Roger Pebody
  • How does a ‘human rights based approach’ work out on the ground? Lessons from South Africa

    While international rhetoric on HIV and AIDS frequently invokes human rights, putting these ideas into practice in specific settings remains challenging, according to a process evaluation of an intervention in rural South Africa published in the October issue of ...

    29 October 2014 | Roger Pebody
More news

Activism news selected from other sources

  • Getting to GIPA 2.0: from Science to Activism

    Bruno Spire is a researcher living with HIV and a senior scientist at the French National Institute for Medical Research (INSERM). Bruno is a scientist, but more so, he is an advocate on HIV community-based research. In this personal narrative, Bruno shares his experience connecting science and activism and how to apply that concept to the GIPA ('Greater Involvement of People Living with HIV/AIDS') principles.

    19 October 2017 | IAS
  • Gilead Continues To Block Ireland From Sourcing Generic Truvada

    Gilead Sciences, the company that supplies Ireland with the drug Truvada, will have a full court hearing in mid-October to determine whether the Irish Health and Safety Executive (HSE) can source a generic analogue of the drug from the pharmaceutical giant’s competitors. In July, GCN reported that Gilead was taking legal action to stop the HSE from securing generic drug from Actavis and Mylan, the company’s competitors, for the purposes of HIV prevention as PrEP.

    16 October 2017 | Gay Community News
  • This Is Exactly How HIV Activists Disrupted Congress to Save Health Care

    Late last month, thousands of Americans with HIV/AIDS -- many of them among the millions of Americans who rely on Medicaid or Affordable Care Act (ACA) plans for their health coverage -- saw the news and breathed yet one more major sigh of relief: the Senate would not go forward on its final effort this year to kill the ACA (aka Obamacare) and take a devastating bite out of Medicaid.

    10 October 2017 | The Body
  • HIV JUSTICE Toolkit to support advocacy against HIV criminalisation now online

    HIV JUSTICE WORLDWIDE today announced the launch of the HIV Justice Toolkit, which aims to support advocates to oppose HIV criminalisation at all levels – from educating communities and lawmakers to defending individual cases.

    10 October 2017 | HIV Justice Network
  • Reconsidering Primary Prevention: a Call To Action For The Global HIV Response

    "The [HIV] prevention toolbox is getting bigger, but the application of the tools is getting smaller. For...prevention to stand a chance, the silence, denial, negativity, and moralism surrounding sex and drug use must end. Policy makers and donors, including governments, must shed their reluctance to openly and positively address sex and drug use in their public health discourse and responses to HIV."

    09 October 2017 | MSMGF
  • What’s a Network of People Living With HIV?

    And what makes it different from other kinds of groups made for people living with HIV? I start the discussion here...

    02 October 2017 | Poz
  • Moments of Stillness

    An interview with photographer Stephen Barker, whose portraits show early AIDS activists, minus all the anger.

    25 September 2017 | Poz
  • South Africa: Aids Activist David Ross Patient Has Died

    World renowned South African AIDS activist David Ross Patient, who was diagnosed with HIV in 1983, died on Friday evening after contracting pneumonia following an operation.

    25 September 2017 | AllAfrica
  • Dear AIDS Activist

    Thank you for your dedication to improving the lives of people living with HIV infection and to efforts to end an epidemic that has gone on far too long. The work you do is even more impressive now, when HIV/AIDS is no longer the cause célèbre it once was and our red ribbon has joined a growing rainbow of good causes and works....Today, the science of HIV can greatly benefit from your true co-production. That means actually demanding to help create research, not just be a mostly mute study team member whose presence allows a box to be check-marked. In an increasing number of research networks, patients are at the drawing board, designing and implementing research. How ironic it is that in HIV research, where the roots of such co-production can be found, we are behind the times.

    21 September 2017 | North Carolina AIDS Training and Education Center
  • PrEP-ing for HIV prevention in Ireland

    Lack of access to HIV pre-exposure prophylaxis (PrEP) is presenting dilemmas for the HSE, clinicians, the medicines regulator and those seeking the medication in Ireland. A recent memo to healthcare professionals sent on behalf of the HSE’s Working Group on HIV pre-exposure prophylaxis (PrEP), discouraging them from directing patients to the activist-led website www.iwantPrEPnow.co.uk for information on sourcing pre-emptive antiretroviral therapy online, is a talking point among campaigners advocating for access.

    18 September 2017 | The Medical Independent
More news


Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.